C2N Diagnostics, LLC

New Filing
CIK: 0002021597·Biotechnology·DELAWARE·Filed: May 6, 2024
Total Offering

$15,000,000

Amount Sold

$7,500,000

Investors

1

First Sale

Mar 1, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Non-Accredited Investors
No

Related Persons

NameRole
Dr. Joel Braunstein
Related Person
Dr. Randall Bateman
Related Person
Dr. Michael Goldblatt
Related Person
Dr. David Holtzman
Related Person
Micah Onixt
Related Person

Company

C2N Diagnostics, LLC

4041 FOREST PARK AVENUE

ST. LOUIS, MO, 63108

877-226-3424

SEC Filing

0002021597-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
C2N Diagnostics, LLC Form D Filing — $15,000,000 | FilingFlow